Results 191 to 200 of about 18,095,855 (237)
Some of the next articles are maybe not open access.
Carboxylate-derived calixarenes with high selectivity for actinium-225
Chemical Communications, 1998The binding properties of two ligands, 5,11,17,23-tetra-tert-butyl-25,26,27,28-tetrakis(carboxymethoxy)calix[4]arene 1 and 5,11,17,23,29,35-hexa-tert-butyl-37,38,39,40,41,42- hexakiscarboxymethoxy)calix[6]arene 2, which show high selectivity for 225Ac3+ (an α-emitter with t1/2 = 10 days) over Na+, K+, Mg2+, Ca2+ and Zn2+ are described.
Xiaoyuan Chen +4 more
openaire +1 more source
Accelerating actinium-225 purification by high-pressure ion chromatography
Journal of Chromatography AActinium-225 (t1/2 = 9.92 days) is an important radioisotope for targeted alpha therapy applications. The limited supply obtained through the decay of thorium-229 has motivated accelerator-based production routes, including irradiation of thorium targets.
Kevin Gaddis +7 more
openaire +2 more sources
Clinical Studies with Bismuth-213 and Actinium-225 for Hematologic Malignancies
Current Radiopharmaceuticals, 2018Due to the shorter range and higher linear energy transfer of α-particles compared to β-particles, targeted α-particle therapy may produce more efficient tumor killing while sparing neighboring healthy cells. We will review the clinical studies using α-particle therapy for Acute Myeloid Leukemia (AML).A series of clinical trials were conducted to ...
openaire +2 more sources
The Coordination Properties and Ionic Radius of Actinium: A 120-Year-Old Enigma
Coordination Chemistry Reviews, 2021Annie B. Kersting +2 more
exaly
Production and Quality Control of Actinium-225 Radiopharmaceuticals
This publication includes existing experiences, lessons learned, challenges and future developments in the production of Ac-225 radiopharmaceuticals for Targeted Alpha Therapy (TAT). This publication will be utilized by all involved professionals in the Targeted Alpha Therapy field, specifying ideal production, formulation, quality control and ...openaire +1 more source

